News HORIBA, Ltd.

Equities

6856

JP3853000002

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
14,785 ^JPY	+1.90%		+3.28%	+34.04%

Apr. 04	Tranche Update on HORIBA, Ltd.'s Equity Buyback Plan announced on February 14, 2024.	CI
Feb. 29	HORIBA, Ltd. Provides Earnings Guidance for the Year 2028	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on HORIBA, Ltd.'s Equity Buyback Plan announced on February 14, 2024.	Apr. 04	CI
HORIBA : Position and Policy Regarding Reduction of Minimum Stock Trading Unit of the…	Mar. 28	PU
HORIBA : Notice of resolutions of the 86th Ordinary General Meeting of Shareholders	Mar. 25	PU
HORIBA, Ltd. Provides Earnings Guidance for the Year 2028	Feb. 28	CI
Jefferies Adjusts Horiba’s Price Target to 15,000 Yen From 13,500 Yen, Keeps at Hold	Feb. 21	MT
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut	Feb. 20	MT
Horiba Starts 5 Billion Yen Share Buyback Program	Feb. 19	MT
Horiba's 2023 Attributable Net Income, Net Sales Rise on Strong Automotive Business	Feb. 19	MT
Jefferies Adjusts Horiba Price Target to 13,500 Yen From 11,000 Yen, Keeps at Hold	Feb. 15	MT
HORIBA, Ltd. announces an Equity Buyback for 530,000 shares, representing 1.25% for ¥5,000 million.	Feb. 14	CI
Horiba, Ltd. Announces Year End Dividend for 2023 , Payable on March 4, 2024	Feb. 14	CI
HORIBA, Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024	Feb. 13	CI
Horiba, Ltd. Provides Dividend Guidance for the Second Quarter End of Year Ending December 31, 2024	Feb. 13	CI
HORIBA, Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	Feb. 13	CI
HORIBA, Ltd. authorizes a Buyback Plan.	Feb. 13	CI
HORIBA : Medical launches next generation HELO fully automated modular hematology solution	Jan. 03	PU
Final dividend	Dec. 27	FA
HORIBA : Acute Leukemia - HORIBA Medical QSP Newsletter #42	Dec. 26	PU
HORIBA : Pyropoikilocytosis - Yumizen Hematology Clinical Cases "Chase the Case" #27	Dec. 18	PU
HORIBA : Presentation material (Q3 2023)	Nov. 24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HORIBA, Ltd.

Equities

6856

JP3853000002

Summary

Filters